GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Calidi Biotherapeutics Inc (AMEX:CLDI) » Definitions » Other Income (Expense)

Calidi Biotherapeutics (Calidi Biotherapeutics) Other Income (Expense) : $6.04 Mil (TTM As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Calidi Biotherapeutics Other Income (Expense)?

Calidi Biotherapeutics's other income expense for the Calidi Biotherapeutics's pretax income for the three months ended in Dec. 2023 was $1.20 Mil. Its other income expense for the trailing twelve months (TTM) ended in Dec. 2023 was $6.04 Mil.

Calidi Biotherapeutics Other Income (Expense) Historical Data

The historical data trend for Calidi Biotherapeutics's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Calidi Biotherapeutics Other Income (Expense) Chart

Calidi Biotherapeutics Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Other Income (Expense)
-1.00 0.17 -2.13 0.66

Calidi Biotherapeutics Quarterly Data
Dec20 Sep21 Dec21 Sep22 Dec22 Jun23 Sep23 Dec23
Other Income (Expense) Get a 7-Day Free Trial 1.66 -2.97 - 4.84 1.20

Calidi Biotherapeutics Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $6.04 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Calidi Biotherapeutics  (AMEX:CLDI) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Calidi Biotherapeutics (Calidi Biotherapeutics) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Calidi Biotherapeutics Inc (AMEX:CLDI) » Definitions » Other Income (Expense)
Comparable Companies
LIFE AVRO GTHX OMER ORMP ELYM MDWD STTK CTMX CAPR OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
11011 North Torrey Pines Road, Suite 200, La Jolla, CA, USA, 92037
Website
https://www.calidibio.com
Calidi Biotherapeutics Inc is a clinical stage immuno-oncology company pioneering the development and commercialization of novel, potent and efficient stem cell-based platforms for delivery and potentiation of oncolytic viruses for the treatment of cancer.

Calidi Biotherapeutics (Calidi Biotherapeutics) Headlines

From GuruFocus

Calidi Biotherapeutics and Unusual Machines Interviews to Air on the RedChip Small Stocks, Big Mone(TM) Show on Bloomberg TV

By ACCESSWIRE • 05-17-2024